TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
QuiaPEG Pharmaceuticals AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
|
211 |
Financial expenses |
25
|
52
|
189 |
Earnings before taxes |
-13,183
|
-12,828
|
-14,533 |
EBITDA |
-9,248
|
-9,590
|
-12,209 |
Total assets |
21,209
|
20,354
|
18,224 |
Current assets |
751
|
1,739
|
1,184 |
Current liabilities |
4,843
|
14,864
|
16,684 |
Equity capital |
16,366
|
5,437
|
1,179 |
- share capital |
156
|
146
|
150 |
Employees (average) |
3
|
4
|
5 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
77.2%
|
26.7%
|
6.5% |
Turnover per employee |
0
![]() |
0
|
42 |
Profit as a percentage of turnover | -6887.7% | ||
Return on assets (ROA) |
-62.0%
|
-62.8%
|
-78.7% |
Current ratio |
15.5%
|
11.7%
|
7.1% |
Return on equity (ROE) |
-80.6%
|
-235.9%
|
-1232.7% |
Change turnover |
0
|
-204
|
-1,604 |
Change turnover % |
-100%
|
-88% | |
Chg. No. of employees |
-1
![]() |
-1
|
2 |
Chg. No. of employees % |
-25%
|
-20%
|
67% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.